Interpretative comments specifically suggesting specialist referral increase the detection of familial

Robert Bender1, Glenn Edwards2, Jenny McMahon2

  • 1Cardiometabolic Service, Royal Perth Hospital, Perth, WA, Australia.

Pathology
|June 23, 2016
PubMed

Insights

Recommending Lipid Disorders Clinic referral for patients with high LDL-cholesterol significantly increased Familial Hypercholesterolemia (FH) detection. This targeted approach improved FH diagnosis rates in the community.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Familial hypercholesterolemia (FH) is an underdiagnosed genetic disorder leading to premature cardiovascular disease due to high LDL-cholesterol.
  • Current diagnostic pathways often miss FH cases, necessitating improved detection strategies.

Purpose of the Study:

  • To evaluate if explicitly recommending referral to a Lipid Disorders Clinic (LDC) improves FH detection rates.
  • To assess the impact of enhanced interpretative comments on lipid results for FH identification.

Main Methods:

  • A prospective case-control study involving individuals with LDL-cholesterol ≥6.5 mmol/L.
  • Cases received interpretative comments suggesting LDC referral, with a subset also receiving the LDC fax number.
  • Controls received standard interpretative comments highlighting possible FH.

Main Results:

  • Referral rates were significantly higher in the case group (18%) compared to controls (8%) (p=0.035).
  • The case group yielded more FH diagnoses (possible, probable, and definite) than the control group.
  • Genetic testing identified causative mutations in 42% of tested individuals.

Conclusions:

  • Interpretative commenting that specifically recommends specialist review augments FH detection in the community.
  • Targeted referral recommendations are effective in increasing the diagnosis of inherited hypercholesterolemia.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
715
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
735